Methodological Considerations in Evaluating CTRP12 as a Biomarker for In‐Stent Restenosis
Clinical Cardiology · 2026-02 · 49 (2)
DOI: 10.1002/clc.70271 ↗At a glance
Leserbrief in Clinical Cardiology, published online on 2026-02-02. Written by Saleha Khattak and 2 co-authors. Institution: Khyber Girls Medical College, Peshawar, Pakistan. 5 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Intet abstract tilgængeligt.
Authors and institutions
- Khyber Girls Medical College, Peshawar, Pakistan.
- Ayub Medical College, Abbottabad, Pakistan.
- Nowshera Medical College, Nowshera, Pakistan.
ORCID profiles: Saleha Khattak, Syed Muhammad Rayyan, Syed Huzaifa Khan
Cite
APA
Khattak, S., Rayyan, S. M., & Khan, S. H. (2026). Methodological Considerations in Evaluating CTRP12 as a Biomarker for In‐Stent Restenosis. Clinical Cardiology, 49(2). https://doi.org/10.1002/clc.70271
Vancouver
Khattak S, Rayyan SM, Khan SH. Methodological Considerations in Evaluating CTRP12 as a Biomarker for In‐Stent Restenosis. Clinical Cardiology. 2026;49(2). doi:10.1002/clc.70271
BibTeX
@article{Khattak2026,
author = {Khattak, Saleha and Rayyan, Syed Muhammad and Khan, Syed Huzaifa},
title = {Methodological Considerations in Evaluating CTRP12 as a Biomarker for In‐Stent Restenosis},
journal = {Clinical Cardiology},
year = {2026},
volume = {49},
number = {2},
doi = {10.1002/clc.70271}
}
EUVIMED